Used in pharmaceutical research as a potential adenosine receptor antagonist, showing activity in modulating neurological pathways. Investigated for its role in developing treatments for neurodegenerative diseases such as Parkinson’s and Alzheimer’s due to its ability to cross the blood-brain barrier. Also serves as a key intermediate in synthesizing purine-derived compounds with anti-inflammatory and anticancer properties. Shows inhibitory effects on specific kinase enzymes, making it valuable in oncology-related drug discovery. Its structural features allow for high binding affinity to target proteins, enhancing its utility in structure-activity relationship (SAR) studies.